Client Profile


TheraVasc Inc. (TheraVasc or “the Company”) is a privately-held biotechnology C-Corp located in Ohio dedicated to reducing the risk, cost and time associated with drug development by focusing on developing repurposed drugs for unserved vascular disease markets. By focusing its efforts on drugs with established safety profiles, targeting diseases that result in a terrible quality of life or rapidly progress to death, and for which no current therapies exist, TheraVasc’s management believes that both patients and clinicians will readily embrace its products, facilitating development. The Company’s first program is ready to enter clinical trials for the treatment of peripheral artery disease (PAD) and other problems associated with poor blood flow to the limbs, including diabetic vascular disease (DVD).

President & CEO
Tony Giordano
Type of Business
Number of Employees
Recent Successes
Received $250K Investment for JumpStart